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Cell factories are important and new tools to produce valuable products without depend-
ing on depleting fossil fuels. As there are successive cell factory constructions, there are 
emerging needs to develop better analysis tools for them. The conventional analysis 
methods such as 2-dimentional electrophoresis and mass spectrometry are certainly eli-
gible for cell factory analysis, but they are not necessarily the most reasonable methods 
because of the need for special equipment. Therefore, new tools for cell factory analysis 
are needed. 
Aldehyde-deformylating oxygenase (ADO) and bacterial luciferase (LuxAB) are inter-
esting target proteins whose bacterial productions were analyzed here: ADO is an en-
zyme involved in fatty alkanes or alkenes generation in bacteria, and LuxAB is an en-
zyme catalyzing the bioluminescence production. Fatty alkanes and alkenes production 
by bacteria is drawing attention since it could replace the traditional chemical produc-
tion of traffic fuels. Bioluminescence is also notable because it can be used as a real-
time monitoring tool for certain bacterial production. 
Therefore, in this study, immunoassay was studied as a new method for cell factory 
analysis. Especially, the immunoassay systems for ADO and LuxAB were constructed. 
The best working scFvs for the immunoassays were successfully selected, and the 
standard curves were also drawn for both of them. Thus, enzyme immunoassay using 
alkaline phosphatase (phoA) for ADO and a new immunoassay for LuxAB were estab-
lished in this study. In the immunoassay for LuxAB, LuxAB generates the signals to be 
measured using exogenously added long-chain aldehyde as substrate, thus no tracer 
scFv or labels are needed. The systems were confirmed to work with ADO and LuxAB 
produced by Escherichia coli but not by Acinetobacter baylyi ADP1. The possible rea-
son could be that A. baylyi ADP1 strains did not produce enough amounts of the pro-
teins for the immunoassays. Thus, further research is still needed, but this study offers a 
meaningful foundation for the development of the immunoassays.   
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BSA Bovine serum albumin 
CH Constant heavy chain 
CL Constant light chain 
VH Variable heavy chain 
VL Variable light chain 
BCCP Biotin carboxyl carrier protein 
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phoA Alkaline phosphatase 
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TMB 3,3′,5,5′-tetratmethylbenzidine 
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1. INTRODUCTION 
Recombination of bacterial cells has become exceedingly common in the engineering 
world today. Especially, the research of cell factories is conducted intensively because 
they offer a way to produce valuable products from raw materials more efficiently than 
what is possible with the existing chemical production methods. Conventional chemical 
production of the valuable products is less environmental friendly and efficient as bio-
technological production with bacterial cells. It is because chemical production very 
often requires petroleum or expensive resources, such as in the production of nylon, 
alkanes or alkenes and wax ester. (Singh, Bhadani and Singh, 2007; Sato, Aoki and 
Noyori, 1998; Mabuza, 2011) There are numbers of bacterial cells which are able to 
produce valuable products naturally, but the production volume does not satisfy indus-
trial needs. Cell factories are the genetically modified cells to produce the targeted 
products in better efficiency or to obtain the ability to produce the targeted products if 
the cell does not possess the pathway for the production yet.  
The more common the construction of the cell factories becomes, the more important 
the analysis of them becomes. Especially, proteomic analysis of the cell factories is aris-
ing to be more important for the development of the technology of cell factories today. 
There are many different methods for the proteomic analysis of the cell factories nowa-
days, but it is always vital to select the most suitable method for the target. The tools 
which have been used in research in other fields, for example, two-dimensional poly-
acrylamide gel electrophoresis (2D-PAGE) or mass spectrometry (MS) could be applied 
to proteomic analysis (Raymond, 1964; Guy and Fenaille, 2006). However, these meth-
ods are not necessarily reasonable for the cell factory analysis in the point of implemen-
tation. Thus, there are obviously needs to invent easier proteomic analysis tools for bac-
terial cell factories.  The goal of this thesis is to provide those analysis tools. 
Immunoassay is an easy and simple method for the proteomic analysis compared to the 
methods mentioned above. There are numerous types of immunoassay systems, but en-
zyme immunoassay is one of the easiest and the safest assays (Yolken , 1986). In im-
munoassay, antibody-antigen interaction is utilized to detect and quantify the amount of 
the target protein. The target antigen binds to the immobilized antibody in the assay 
system, and the antigen is labelled with a substance which generates signals, or different 
antibody specific to the same antigen is labelled and added to the system after antigen. 
The labels generate signals, for example, colour change or luminescence. Enzyme im-
munoassay does not require any special certificates or treatments of the wastes as radio-
immunoassay requires (Sancho, Amal and Garcia-Fayos, 2013). The procedure consists 
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of only addition of the samples, incubation, washing of the plates, and the measurement 
of the signals, which is moderately simple.  
This study suggests enzyme immunoassay as a proteomic analysis tool for wax ester 
producing cells, recombinant Acinetobacter baylyi ADP1 cells, by constructing the suit-
able immunoassay system for them. In this study, the most suitable single-chain varia-
ble fragments (scFv) for aldehyde-deformylating oxygenase (ADO) and bacterial lucif-
erase (LuxAB) produced by the modified A. baylyi ADP1 were selected by testing the 
immunoassay systems. Since these A.baylyi ADP1 strains were relatively new strains, 
the systems were initially tested with ADO and LuxAB produced by recombinant Esch-
erichia coli XL1 for the scFv selection to confirm that the systems work properly. For 
LuxAB immunoassay, a new type of enzyme immunoassay in which the antigen gener-
ates the signal as luminescence without any labels is established. In the end, the con-
firmed immunoassay systems were applied with ADO and LuxAB produced by A. 
baylyi ADP1, and the results were analysed.  
Construction of the immunoassay system for A. baylyi ADP1 producing ADO or Lux-
AB will be useful for developing biochemical alkanes, alkenes or wax ester production 
with bacterial cells. It is a more eco-friendly method for the production of them than the 
chemical production, contributing to reduce the negative effects on environment.  
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2. CELL FACTORIES 
Today, cell factories are very important in biotechnology as mentioned in introduction. 
Cell factories are the microbial cells which are engineered to produce valuable products 
from raw ingredients. They have the potentials to replace the chemical production 
which are not environmental-friendly once appropriate processes with cell factories are 
developed. To obtain environmental-friendly world with using cell factories, technolo-
gies for their designs and analysis have to be developed.  
2.1 Cell Factory Design and Synthetic Biology   
To design desired cell factories, metabolic engineering has been playing a very im-
portant role for a long time. In metabolic engineering, the metabolic fluxes of microbial 
cells are analysed and improved by, for example, adding continuation to specific meta-
bolic fluxes or deleting undesired fluxes. It has been leading the biotechnological re-
search, but synthetic biotechnology is rapidly developing as a tool for cell factory de-
sign these days in addition to metabolic engineering. In synthetic biotechnology, genetic 
circuits are created and introduced to the cells to obtain desired products. The term syn-
thetic biology was already invented in 1912 by Stephane Leduc, but it started to be no-
ticed only recently (de Lorenzo and Danchin, 2008). As shown below in Figure 1, it has 
been developing since the start of 21
st
 century very quickly (Fong, 2014).  
 
   
Figure 1. Development of synthetic biology. Synthetic biology has rapidly developed 
since 2000. Modified from (Fong, 2014). 
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In synthetic biology, it is important to have the proper and suitable data sources, such as 
scientific literature, bioinformatics databases, and in silico design tools as shown in 
Figure 2. Having reliable sources is important because accurate data of DNA sequences 
and characterization and experimental data are essential in designing production path-
ways for the cell factories. To design effective and feasible cell factories, it is always 
necessary to have the reliable and accurate information of the Bioparts to be used. For 
example, Synthetic Biology Open Language (SBOL) is one of the tools for exchanging 
the characteristics of Bioparts between different systems. The selection of the data 
sources should be conducted properly, and also the obtained data should be analysed for 
the design if needed (Gibson et al., 2010).    
 
 
Finally, the Bioparts are designed, and the parts are assembled. One of the most im-
portant elements to be discussed about the assembly of Bioparts is the standard biologi-
cal parts, often referred as Biobrick parts. Biobrick parts allowed researchers to focus on 
their research without caring about the restriction enzymes to be used. Figure 3 shows 
the example of assembly of Biobrick parts. In this example, since SpeI and XbaI have 
the same restriction end, the restricted sites of Part A and Part B can be ligated together. 
Figure 2. Description of synthetic biology process. In synthesis of cells, it is re-
quired to have suitable data sources in the beginning. After that, required Bioparts 
are selected, and the designing, assembly, and the test of the cells are conducted . 
These three steps are conducted repeatedly until the ideal results are obtained. 
Modified from (Kelwick et al., 2014). 
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As it can be seen from this example, Biobrick parts have the standardized restriction 
ends, SpeI, XbaI, PstI and EcoRI, making it possible for us to simply use those parts 
without having trouble with looking for suitable restriction sites every time. (Wang et 
al., 2011; Shetty, Endy and Knight Jr., 2008) Using this technology, the creation of new 
gene circuits has become much easier and less troublesome, enabling the cell factory 
design with synthetic biology.   
 
Figure 3. Assembly of Biobrick parts. PartA has SpeI and PstI restriction sites, and 
Part B has XbaI and PstI restriction sites in this figure. The ligation of them can be 
conducted easily because SpeI and XbaI have the same restriction sites. Modified from 
(Wang et al., 2011). 
In the end, the synthesized cells are tested for the eligibility, and the synthesis of cell 
factories is accomplished completely (Figure 2).  
2.2 Examples of Cell Factory Design with Synthetic Biology 
A good example of a cell factory design with synthetic biology has been conducted by 
Santala (2014). Santala (2014) succeeded in reconstructing a wax ester producing flux 
with A. baylyi ADP1 strain. A. baylyi ADP1 possesses the pathway to produce wax ester 
naturally. However, the natural pathway was knocked out in the research, and a new 
pathway was introduced to make the wax ester production easier to control. In this case, 
fatty-acyl coenzyme A (acyl-CoA) gene, acr1, was knocked out, and luxCDE was in-
troduced with Arabinose promoter (Figure 4). LuxC, D, and E are fatty acid reductase, 
acyl transferase, and acyl-protein synthetase, respectively. As mentioned above, arabi-
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nose promoter was also introduced to the strain, which enables the regulation of the wax 
ester production. (Santala et al., 2014) This novel study shows the importance of syn-
thetic biology in the production of valuable products by replacing the natural pathway 
with synthetic pathway.  
 
Figure 4. Metabolic flux of engineered Acinobacter baylyi ADP1. It produces wax ester 
through synthesized pathway. The fatty-acyl coenzyme A (acyl-CoA) gene in (a) is 
knocked out and LuxCDE gene is introduced in (b). The synthesized cassette LuxCDE is 
shown in the bottom of the figure in detail. Modified from (Santala et al., 2014). 
As mentioned earlier, cell factory design could be directly useful in productions of nov-
el products, but it has also been used for biosensor. Santala (2011) has succeeded in 
monitoring the production of wax ester by A. baylyi ADP1 strain with bioluminescence. 
Luminescence-producing enzyme, LuxAB, was introduced into A. baylyi ADP1 strain 
using synthetic cassette, and the luminescence was observed during the cultivation since 
long-chain aldehyde is produced by the strain during wax ester production. (Santala et 
al., 2011) This method was employed as an analytical tool for the above-mentioned 
study by Santala (2014).  
There is also research which has succeeded in producing alkanes or alkenes using syn-
thetic biology. Kallio (2014) was able to produce propane from glucose by engineered 
E. coli which was modified to express aldehyde-deformylating oxygenase (ADO). 
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(Kallio et al., 2014) ADO is an important protein in producing alkane and alkenes. This 
protein is explained in more details in the next section. Crépin (2016) succeeded in pro-
ducing alkanes and alkenes by expressing acyl-ACP and ADO in Cupriavidus necator 
which does not possess the pathway to produce alkanes or alkenes naturally. In their 
research, they were also able to use CO2 as the only carbon source for fatty alkanes and 
alkenes production. (Crépin , Lombard and Guillouet, 2016)  
From these examples, it can be said that the use of synthetic biology is not limited, in-
creasing the possibilities for the cell factory design. Furthermore, it also implies the 
necessity of inventing and improving the analytical tools for the cell factories. 
2.3 Proteins useful in cell factory constructions 
Examples of the proteins drawing attention in cell factory research today are ADO and 
Bacterial Luciferase (LuxAB). ADO is an enzyme which catalyzes the conversion of 
fatty aldehydes to fatty alkanes or alkenes. Fatty alkanes and alkenes are necessary in 
this world since they are the main constituents of fossil fuels (Mabuza, 2011; Howard et 
al., 2013). However, because the depletion of the fossil fuels is becoming more and 
more serious today, it is important to develop other methods to produce them. Biosyn-
thesis is one of those new methods, and it is considered as a promising system to solve 
this problem. That is why ADO is an essential enzyme to be researched. Its function and 
mechanism of the catalysis of fatty alkanes or alkenes production has been recently in-
vestigated. It has been discovered that cyanobacteria have this pathway to produce fatty 
alkanes or alkenes using ADO naturally. In cyanobacteria, fatty acids store the energy 
obtained from the sunlight, and the fatty acids are converted into fatty aldehydes by 
acyl-acyl carrier protein (acyl-ACP). These fatty aldehydes are then converted into fatty 
alkanes or alkenes by ADO. (Rajakovich et al., 2015) For this reaction, O2 molecule and 
four electrons are required for with fatty aldehyde, and the products of this reaction are 
fatty alkane or alkene and formate (Warui et al., 2011; Li et al., 2011). However, though 
some examples are introduced in the previous section, there is not yet much research 
which has succeeded in producing the fatty alkanes or alkenes by expressing ADO in 
bacteria not able to produce them naturally.  
LuxAB is an enzyme existing in luminous bacteria which is able to catalyze the genera-
tion of luminescence as mentioned earlier. There are mainly three types of biolumines-
cent organisms, Vibrio, Photobacterium, and Photorhabdus (Xenorhabdus). The lux 
operon includes luxA, luxB, luxC, luxD, luxE, and luxG, and luxA and luxB encode for 
the bacterial luciferase. It is well known that long-chain aldehydes, FMNH2, and O2 are 
required for bioluminescence production for LuxAB. When the bacteria possess the 
genes luxD, luxC and luxE which encode enzymes LuxD, LuxC, and LuxE, they cata-
lyze the reaction to generate long-chain aldehyde from fatty acyl group. LuxD, LuxC, 
and LuxE are transferase, reductase and synthetase, respectively. In addition to that, if 
the gene luxG is also included, LuxG which is encoded by luxG catalyze generation of 
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FMNH2. (Figure 5) As the bioluminescence research has been conducted intensively, it 
is possible to express luxA and luxB in bacteria not naturally producing luminescence, 
such as in E. coli. In this kind of case, the aldehyde needs to be provided exogenously. 
(Close et al., 2012; Tinikul and Chaiyen, 2016; Close, Ripp and Sayler, 2009) The reac-
tion of bioluminescent generation with lux operon is described in Figure 5. Luciferase 
catalyzes the oxidation of FMNH2 and long-chain aldehyde, so FMN, carboxylic acid, 
H2O, and luminescence are obtained. The obtained light is 490 nm whose color is blue 
to green. (Tinikul and Chaiyen, 2016) 
 
Figure 5. Reaction of bioluminescent generation with lux operon.luxA and luxB encode 
for bacterial luciferase, and luxC, luxD, and luxE encode for reductasse, transferase, 
and synthetase which are related to the long-chain aldehyde production. luxG encodes 
for the enzyme which catalyze the reaction of FMNH2 production. Modified from 
(Tinikul and Chaiyen, 2016).  
LuxAB is researched intensively in bioengineering because it can be utilized in biosen-
sor systems. A typical biosensor system using LuxAB is the determination of the toxic 
compounds levels of, for example, wastewater and soil. In this kind of system, luxAB is 
employed in microorganisms, and they are exposed to toxic compounds during the cul-
tivation. When the microorganisms are exposed to the toxicity, the bioluminescence 
generation should decrease. The toxic compounds could be, for example, cadmium, 
mercury, or nano-Copper oxide, depending on the microorganism. As a result of the 
measurement of toxicity, EC50 of each toxic compound is compared. EC50 is the concen-
tration of toxicity which caused the 50 percent loss of the luminescent.  (Park, Hwang 
and Kim, 2002; Anjum et al., 2015) Microtox is a representative tool which is used to 
test the toxicity using this principle. (Johnson, 2005) In addition to the toxicity test, 
LuxAB is employed as a real-time monitoring tool of the cell factories today, indicating 
that it can be also used as a cell factory analysis tool. As explained in 2.2 as an example, 
Santala (2011) has succeeded in constructing a real-time monitoring system of wax es-
ter production of A. baylyi ADP1. LuxAB was expressed by A. baylyi ADP1 producing 
wax ester using the long-chain aldehyde which was an intermediate of wax ester pro-
duction. Thus, it was possible to monitor the growth of the cells and the wax ester pro-
duction by measuring the level of luminescence. (Santala et al., 2011) This is a novel 
and new approach of the use of LuxAB in the cell factory analysis, so it could be said 
that there are still a lot of potentials to utilize LuxAB as a monitoring tool into other 
cells as well.   
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3. PROTEOMIC ANALYSIS  
Proteomic analysis, also called proteomics, is a relatively new concept in biotechnologi-
cal research which studies the proteome. After this concept had been acknowledged in 
some means by researchers, the term “proteomics” was introduced by Wilkins (1995), 
establishing it as a concrete field of research (Wilkins et al., 1996). The term “proteo-
me” was created from “the entire PROTein complement expressed by genOME, or by a 
cell or tissue type”, according to Wilkins (1995). Since the introduction of the concept, 
numbers of proteomic tools have been developed, such as 2D-PAGE, MS, and protein 
arrays. The principles of them are explained in the following sections. 
3.1 2-dimensional polyacrylamide gel electrophoresis (2D-
PAGE)  
2D-PAGE was one of the first technologies used for proteomic analysis, and it is a 
combination of isoelectric focusing (IEF) and sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE). There were numbers of works conducted on two-
dimensional electrophoresis (2D) already in 1960’s. 2D utilizes two types of electropho-
resis, which makes it useful in separating the samples containing many different pro-
teins in biotechnological experiments. Among the works conducted on 2D, one of the 
most remarkable researches was conducted by Kenrick and Margolis who succeeded in 
protein separation by 2D technique combining native IEF and SDS-PAGE in 1970. This 
was named as 2D-PAGE. (Raymond, 1964; Orrick, Olson and Busch, 1973; James, 
1997)  As illustrated in Figure 6, in 2D-PAGE, the first electrophoresis, isoelectric fo-
cusing, separates the proteins in one dimension, and then the second electrophoresis, 
SDS-PAGE, separate them to another dimension. The two separations are done using 
two different parameters, and it was possible to obtain higher resolution with this meth-
od.  
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However, five years later, O’Farrel (1975) and Klose (1975) invented new methods us-
ing denaturing IEF, which are one of the most typical 2D-PAGE techniques nowadays 
(O'Farrell, 1975; Klose, 1975). The resolution and sensitivity have been improved even 
more with this method, which opened up the potentiality of 2D-PAGE to be used in 
proteomic analysis. 2D-PAGE technique has been developed even further since this 
innovative event, for example, by changing the gels for IEF to ultrathin polyacrylamide 
gels or replacing IEF with Blue-Native-PAGE (Görg, Postel and Westermeier, 1978; 
Camacho-Carvajal et al., 2004). These allowed to obtaining more improved resolution. 
However, it was still possible only to quantify the proteins by staining the 2D-PAGE 
gels after separation, but not to identify them. Therefore, analysis tools which are able 
to identify the proteins started to appear for proteomic analysis.  
Figure 6. Schematic chart of principle of 2D gel electrophoresis. In 2D gel electropho-
resis, firstly, the extracted proteins are separated to one dimension by isoelectric focus-
ing according to their pIs.. After that, they are separated to another dimension by sodi-
um dodecyl sulfate polyacrylamide gel electrophoresis according to the molecular mass-
es of the proteins. Modified from (Rabilloud and Lelong, 2011). 
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3.2 Mass spectrometry (MS) 
Proteomic analysis using MS could be mentioned as an essential method in this field of 
research today. It enabled the identification in addition to the quantification of proteins 
which was not possible by using only 2D-PAGE. The history of MS starts from the time 
when Joseph John Thomson succeeded in determining the mass-to-charge ration of 
electrons in 1897 (Gottfried, 2013). Since its advent, MS has been playing an important 
role in variety of analysis, for example, clinical analysis and food analysis (Vogeser, 
2010; Guy and Fenaille, 2006).  
Mass to charge ratio (m/z) can be measured with MS by ionizing the targeted analyte. 
As described in Figure 7, mass spectrometer consists of ionization source, mass analyz-
er, and detector. 
 
Figure 7. Schematic chart of MS. MS consists of ionization source, mass analyzer, and 
detector. The signals are the in the end analyzed by computer. Modified from (Kicman, 
Parkin and Iles, 2007). 
The ionization of the analyte is usually conducted with matrix-assisted laser desorption 
ionization (MALDI) or electrospray ionization (ESI) since their appearance in 1990’s 
(Whitelegge et al., 1999; Liu et al., 2011; Susnea et al., 2013). These methods are called 
“soft ionization” because the fragmentation which happens by them is small. As a mass 
analyzer, time-of-flight mass spectrometry (TOFMS) is frequently used with MALDI, 
and quadrupole MS is very often combined with ESI.  
The principle of MALDI-TOFMS is described below in Figure 8. Firstly, the analyte is 
mixed with UV-absorbing matrix, for example, sinapinic acid or gentisic acid, and this 
mixture becomes crystalized on MALDI plate. The matrix absorbs the energy from the 
laser light produced by MALDI and isolates each protein molecules when big molar 
excess exists in solid matrix (Chait and Kent, 1992). The crystalized mixture is then 
exposed to the laser light, and it is ionized and desorbed. Then, the proton is transferred 
from the matrix to the analyte. After that, the protonated molecules are accelerated by a 
potential difference and enter into the flight tube (mass analyzer). The m/z of the ana-
lyte is measured based on the time which took for the protonated molecules to fly 
through the tube and reach the detector (time-of-flight). (Kicman, Parkin and Iles, 2007; 
Marvin, Robrets and Fay, 2003)   
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Figure 8. Schematic chart of MALDI-TOFMS. The analyte is mixed with UV-absorbing 
matrix, and this mixture is crystalized on the MALDI plate. After they have been ex-
posed to laser light, the protonated molecules fly into the mass analyzer by the potential 
difference. Time-of-flight, the time which took for the protonated molecules to fly 
through the mass analyzer, is measured, and m/z of the analyte can be calculated. 
Modified from (Marvin, Robrets and Fay, 2003). 
ESI-quadrupole mass analyzer’s principle is shown in Figure 9 (a). In the first part, ESI, 
liquid sample is flown through a capillary where potential gradient is applied from the 
tip. There is also gas provided in small capillaries attached to the capillary, which 
sprays out the analyte. By this process, charged droplets are created. After this, the 
droplets become smaller by solvent evaporation, and they repulse each other because of 
their electrical charges. This makes the diameters of droplets even smaller, and the 
small droplets pass through the counter and skimmer electrodes. The analyte molecules 
finally enter into the mass analyzer with high vacuum after this process. (Gaskell, 1997; 
Zhang et al., 2013) 
Quadrupole mass analyzer consists of four electrically charged rods as shown in Figure 
9 (b). They are placed so that the two rods with the same charge are on the opposite 
side. The electrical charge applied is created by radio frequency which is 180 degrees 
different on the opposite rods. The analyte ions enter into the quadrupole mass analyzer 
and fly through the space between the rods by the electrical field. However, by adjusting 
the DC and radiofrequency voltages, the ions which do not have certain m/z cannot con-
tinue drawing the stable trajectory, therefore this electrical field works as a filter. In the 
end, only the ions which were able to fly through the analyzer reach the detector. 
(Yinon, 2009; Kicman, Parkin and Iles, 2007) 
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Figure 9. Schematic chart of (a) ESI and (b) quadrupole MS. (a) In ESI, liquid sample 
is flown through the capillary by potential gradient. The analyte is sprayed out by gas 
and charged droplets are generated. The droplets repeat the fission and the small drop-
lets goes through the electrodes, and they reach the analyzer. (b) In ESI-quadrupole MS, 
the analyte which flew through ESI reaches quadrupole, and the ions fly to the space 
created by the electrically charged rods. When the DC and radiofrequency voltages are 
adjusted, ions which do not have certain m/z cannot stably fly anymore. As a result, 
only the ions with certain m/z can reach the detector. Modified from (Gaskell, 1997; 
Kicman, Parkin and Iles, 2007). 
There are also ion-trap mass analyzer and Fourier-transform ion cyclotron resonance 
(FTICR) mass analyzer which can be combined with MALDI or ESI (Figure 10). Ion-
trap mass analyzer utilizes similar principle as quadrupole. The difference is that it traps 
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the ions in the region between the electrodes, but the analyzer does not work as a filter 
as in quadrupole mass analyzer (Sleeman and Carter, 2005). The trapped ions in ion-
trap mass analyzer are screened by radiofrequency voltage. Only the stable ions stay in 
the analyzer when certain voltage is applied. In FTICR, ions are trapped by magnetic 
field. Then, the signals from ions are detected as frequency from which m/z can be cal-
culated. By FTICR, very high resolution can be achieved. (Scigelova et al., 2011) 
 
Figure 10. Descriptions of (a) Ion-trap mass analyzer and (b) FTICR. In (a), ions are 
trapped between the electrodes, and they are screened by radiofrequency voltage. Only 
stable ones can stay in the analyzer when certain voltage is applied. In (b), ions are 
trapped by magnetic field, and m/z of them is calculated from the obtained frequency. 
Modified from (Sleeman and Carter, 2005; Twyman, 2005). 
These are the methods to identify proteins by measuring m/z. As described above, when 
the sample is in solid phase, MALDI-TOFMS should be used, and when it is in liquid 
phase, ESI-quadrupole is suitable. However, there are also other approaches to the iden-
tifications of proteins.  
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3.3 Analytical Protein Microarray - Immunoassay 
Protein microarray has surface to which certain proteins are attached. These proteins are 
exposed to the analyte, and certain proteins are captured. Because protein microarray 
has many wells on one plate, it makes parallel analysis possible and requires less time 
compared to 2D-PAGE or MS. It is also more suitable for identifying low-abundant 
analyte. (Rigbolt and Blagoev, 2012) For the reasons above, this technology has been 
progressively researched for proteomic analysis today. Protein microarray can be main-
ly classified into two main types; analytical protein microarray and functional protein 
microarray. 
Immunoassay is an analytical tool which can be applied in microarray format, and it 
utilizes the antibody-antigen interaction. Its history dates back to 1959 when Yalow and 
Berson succeeded for the first time in using radioimmunoassay for bioanalysis. (Yalow 
and Berson, 1959) Since then, immunoassay has been applied increasingly, and it has 
become one of the most important tools in proteomic analysis recently. In protein mi-
croarray, protein which detects the analyte can be attached to the bottom of each well of 
the microtiter plates. For immunoassay, microtiter plates are very often used, so the 
samples could be added as liquid to each well. The proteins to detect the analyte are 
antibodies in immunoassay because of their high specificity and sensitivity towards the 
antigens, enabling accurate measurements.  
3.3.1 Types of immunoassays and their principles 
Immunoassays can be divided into competitive immunoassay and non-competitive im-
munoassay. Competitive immunoassay is shown in Figure 11. In this type of immuno-
assay, firstly, antibody is immobilized to the wells of microplate. Then, the blocking 
agent is added to the wells. This blocking agent is added to block the unspecific binding 
of the antigens to be added later to the surface of the wells. Bovine serum albumin 
(BSA) is often used as the blocking agent in the wash buffer for the assay system. The 
plates are washed, so that the excess amount of antibodies or antigens does not disturb 
the whole system. After that, the target antigen and the known amount of labeled anti-
gen are added to the wells. The labeled antigens are attached, for example, with en-
zymes or radioisotopes. Therefore, when the antigens are bound to the antibodies and 
the substrates are added, measurable signal could be observed, such as absorbance or 
radioactivity. Since known amount of the labeled antigens are used, the amount of non-
labeled antigens can be calculated. (Yu, Jiang and Cui, 2014) 
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Figure 11. Schematic picture of competitive immunoassay. Antibody is immobilized to 
the wells of the plate, and the blocking agent is also added to the wells to prevent un-
specific binding. Target antigen and enzyme-labeled antigen are added, and the signals 
are measured. Modified from (Yu, Jiang and Cui, 2014). 
The non-competitive immunoassay, on the other hand, works in a slightly different way 
as described in Figure 12. It is also called as sandwich immunoassay. In Figure 12, en-
zyme non-competitive immunoassay is described as an example. In non-competitive 
immunoassay, there are antibodies adhered to the microplate as in step 1 (capture anti-
bodies) and also the ones adhere to the antigen as in step 3 (tracer antibodies). The trac-
er antibodies are labeled, and the signals are obtained. The signal is absorbance in this 
case. (Yolken , 1986) This type of immunoassay is effective especially when antigen 
has two or more epitopes (Wisdom, 1976).  There are no competitions between labeled 
antigens and not labeled antigens in this type of immunoassay compared to the competi-
tive immunoassay, which is why it is called non-competitive immunoassay.  
 
Figure 12. Principle of enzyme sandwich immunoassay. 1. Antibody specific to the tar-
get antigen (AB1) is adhered to the surface of the plate. 2. Antigen binds to AB1. 3. En-
zyme-labeled antibody is added, and it attaches to the antigen. 4. Substrate of the en-
zyme is added, and the signal is produced by the reaction of enzyme and its substrate. 
Modified from (Yolken , 1986). 
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3.3.2 Substitutes for antibodies 
For the immunoassay, capturing and tracing of the antigen does not always have to be 
done with the whole antibodies. Aptamers have been rising in to be a substitute for the 
antibodies during these 20 years. Aptamers are the single-stranded DNA or RNA which 
bind to specific ligands. They consist of 20 to 60 nucleotides and form three-
dimensional conformations for the specific binding. (O'Sullivan, 2002; Chen and Yang, 
2015; Xu et al., 2015) There have been research proving that aptamers are able to bind 
to small molecules too, for example, nucleoside, antibiotics, and fluorescent dyes 
(Haller and Sarnow, 1997; Song et al., 2012; Wilson and W Szostak, 1998). Aptamers 
are able to bind to their ligands in a similar way as antibodies, but they have many ad-
vantages over antibodies such as; the target could be non-immunogenic compounds too, 
the selection could be done more easily in vitro, lower cost chemical synthesis is possi-
ble, not sensitive for redox, pH or temperature, and the difference among the batches are 
smaller. For these reasons, aptamers are suitable candidates for the substitutes for anti-
bodies in immunoassay.  (Chen and Yang, 2015) 
Single-chain variable fragments (scFvs) are also used for immunoassays instead of anti-
bodies. As shown in Figure 13, scFv is a recombinant protein consisting of light chain 
of variable region (VL) and heavy chain of variable region (VH) domains of antibody 
domains linked together by a short peptide. The sizes of scFvs are usually 25kDa. This 
means that they are approximately six times smaller than antibodies, but they still main-
tain the ability to bind to the specific target of the original antibody. (Reddy and 
Robinson, 2010; De Meyer, Muyldermans and Depicker, 2014; Kierny, Cunningham 
and Kay, 2012) Other advantages of scFvs are the easiness for the gene manipulation 
for the improvement of their functions and the possibility of isolation by phage display 
from naïve libraries enabling rapid generation of them.  (Cois, Hudson and Irving, 2001; 
El-Magd et al., 2016; Buckler et al., 2008) Due to the reasons above, the substitutes for 
antibodies are used more extensively nowadays. 
 
Figure 13. Schematic description of conventional antibody and scFv. scFv consists of 
variable light and heavy chain bound with peptide chain. Modified from (De Meyer, 
Muyldermans and Depicker, 2014). Abbreviations; CH heavy chain (constant), CL light 
chain (constant), VH heavy chain (variable), VL light chain (variable). 
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3.3.3 Immobilizations of antibodies and their substitutes 
There are several methods to immobilize the antibodies to the wells for immunoassay. 
The easiest method for the immobilization is physical adsorption caused by hydropho-
bicity. The stableness of the adsorption depends highly on the materials of the surface or 
the characteristics of the samples. As mentioned above, it is the easiest method, but it 
has been proved that adsorption could cause conformation change to antibodies since it 
is not possible to adjust the orientation of the antibodies (Butler et al., 1992). Therefore, 
other methods have also been developed for antibody immobilization to overcome those 
problems.  
Covalent attachment is one of these methods. By using covalent linking, the strength 
and the orientation of the attachment can be improved.  An often-used technique of co-
valent immobilization is the covalent bond built by benzoquinone function and peptides 
containing cyclopentadiene. This is one of the most representative combinations in test-
ing the activity of protein kinase. (Houseman et al., 2002)  
There are also non-adsorptive or covalent methods for the immobilization. The most 
famous methods of them are the ones with streptavidin-biotin  interaction  which  is  
known  for  the  high  affinity  between them. To utilize this interaction, the wells of 
microtiter plate can be coated with streptavidin, and the protein (e. g. antibodies) to be 
immobilized can be biotinylated. Zhu (2014), for example, has succeeded in conducting 
a sandwich immunoassay utilizing this interaction into the analysis of virus for clinical 
use. Traditionally, biotinylation has been conducted with the chemical methods. How-
ever, with chemical methods, it is difficult to control to which sites of the antibodies 
biotin attach. Therefore, Santala (2004) described a new method to attach biotin to scFv. 
In this method, scFv is fused with biotin carboxyl carrier protein (BCCP) which binds to 
biotin inside the cells (Santala and Lammimmäki, 2004). The design of the scFv-BCCP 
fusion is possible with this technique, thus the orientation of the scFvs attached to biotin 
could be homogenous in the system.  
3.3.4 Selection of the antibodies for immunoassay 
To conduct immunoassays, specific proteins which bind to the target have to be selected. 
Phage display and biopanning are one of the techniques for the selection, and they are 
commonly used together sequentially. In phage display, proteins, peptides or antibodies, 
are displayed on bacteriophages. Phage display technology enables us to select specific 
binder proteins from a diverse protein library. Ff E. coli phages (f1, fd, M13), filamen-
tous phages which replicate episomally, are often used for phage display. For phage 
display, the genes of the target molecules to be displayed are fused to the phage genes 
of the coat proteins. There are two coat proteins mainly used for phage display; major 
coat protein pVIII and minor coat protein pIII. (Figure 14) (Rakonjac et al., 2011) Major 
protein pVIII possesses α-helix structure, and its number of copies is 2700, making it 
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the most abundant. But, when the length of peptides is more than six, it copies in small-
er numbers because of the structural problem. (Hoess, 2001) On the other hand, the 
number of copies of pIII is only five, but it does not have strict limitation for the length 
of the peptide to be fused with. pIII is composed with three domains; N1, N2 and C do-
mains. These three domains are linked by glycine linkers. (Bazan, Calkosinski and 
Gamian, 2012) This coat protein plays important roles in the infection of phage (Figure 
14). Firstly, N2 domain of pIII binds to the receptor, tip of the F-pilus. This triggers the 
conformational change of N2 domain, and the N1 domain is released. N1 domain then 
binds to the TolA-III. TolA works as a co-receptor in the infection of E. coli, and TolA-
III is the C-terminal domain of its three domains. (Riechmann and Holliger, 1997) After 
that, C-domain of pIII coat protein opens up, and the coat proteins enter to the inner 
membrane. The complex of TolA, TolQ, and TolR mediates the process of the integra-
tion of the coat proteins pIII and pVIII to cytoplasmic membrane and entry of ssDNA 
into the cytoplasm. (Karlsson, 2004; Rakonjac et al., 2011; Grönwall and Stahl, 2009) 
However, the steps which N2 domain of pIII binds to TolA-III and C-domain of pIII 
opens up are still speculative. Thus, there needs to be more research to elucidate the 
phage infection mechanism.  
 
Figure 14. Scheme of bacterial infection. Modified from (Rakonjac et al., 2011). 1. N2 
domain of pIII (dark blue oval) binds to the F-pilus of the phage (light blue circles). The 
structure of the phage coat protein can be seen as well from this picture. 2. N1 domain 
of pIII (green oval) binds to TolA-III (brown oval). 3. C-domain of pIII (orange oval) 
opens up, and the coat proteins enters to the inner membrane. 4. The complex of TolA, 
TolQ (dark brown oval), and TolR (light brown oval) mediates the process of the inte-
gration of the coat proteins pIII and pVIII(black rectangles) to cytoplasmic membrane 
and entry of ssDNA into the cytoplasm.  
20 
To generate the proteins, peptides, or antibodies to be displayed, phage vector or 
phagemid vector with helper phage are commonly used. Phage vector contains the 
genes of the fused pIII and the molecule to be displayed, origins of replication, and 
phage structural protein. Thus, phage vector contains genes of all the essential proteins 
for phage infection. On the other hand, phagemid vector contains only the fused genes 
for the coat protein pIII and the molecule to be displayed, origins of replication of E. 
coli and the phage, and antibiotics resistance. However, since it does not contain the 
genes for the other phage proteins, the phage cannot be constructed by phagemid plas-
mid alone. Therefore, after the phagemid vector is transformed to E. coli, helper phage 
is superinfected to provide those proteins. (Figure 15)  
Phage display of antibodies has been researched since 1990 (McCafferty et al., 1990; 
Rondot et al., 2001; Kugler et al., 2015). Antibodies can be displayed in the form of 
scFv or Fab on phage (Figure 16). When it takes scFv form, VH and VL genes linked by 
short peptide (Gly4Ser)3 are inserted into the phagemid vector. The C-terminus of VL is 
attached to the gene of pIII protein. (Pansri et al., 2009). In contrast, when it takes the 
form of Fab, genes of CH1 and CL are inserted to the phagemid vector too. They are 
inserted to be so that the C-terminus of VH is attached to CH1 and the C-terminus of VL 
is attached to CL. Then, the C-terminus of CH1 or CL is attached to the pIII protein. 
(Hoogenboom et al., 1991) The advantage of Fab is that scFv tends to dimerize, but Fab 
does not have this tendency. When scFv takes the dimerized form or higher oligomers, 
it makes the selection more complicated in phage display. (Holliger, Prospero and 
Figure 15. Schematic description of phage infection by phagimid plasmid and helper 
phage. Modified from (Qi et al., 2012). The phagemid vector contains genes for pro-
moter, signal, displayed protein, peptide or antibody, and phage coat protein. It also 
contains the origin of phage and plasmid. After the plasmid is transformed to the cells, 
the cells are superinfected with helper phage for the generation of structural and func-
tional proteins for phage.  
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Winter, 1993; Kortt et al., 1994) However, it is studied that scFv expression is less toxic 
for the growth of the cells than Fab expression (Amdt, Muller and Pluckthun, 2001).  
 
The antibody phage library indicates the collection of those phages displaying antibody 
fragments. There are three types of antibody libraries; immune library, naïve library, 
and synthetic antibody library. Immune library is constructed with the antibody frag-
ments isolated from lymphocyte cells of immunized animals, e. g. mouse, chicken, and 
rabbit (Ørum et al., 1993; Chiliza, Van Wyngaardte and Du Plessis, 2008; Popkov et al., 
2003). The source could also be the patients of cancer or human which has taken the 
target antigen as vaccination (Wu et al., 2001; Cai and Garen, 1995). The antibody 
fragments, scFv or Fab, are amplified by PCR from cDNA of those lymphocyte cells. 
Therefore, the antibodies obtained from this library are highly specific to the antigen, 
enabling to isolate the antibodies possessing high-specific and high-affinity to the target 
from small sized library. However, the drawback of immune library is that the library 
needs to be specifically constructed to the targeted antigen. Naïve library is also called 
non-immune library, which means that its source is lymphocyte cells of non-immunized 
animals or healthy humans. Because the cells do not go through the immunization, the 
antibodies do not show as good affinity as the ones from immune library. To obtain 
high affinity antibodies, the size of the library needs to be large. (Schwimmer et al., 
2013) While the source of immune library and naïve library is natural source, the anti-
body fragments are artificially designed to be rational for synthetic library. The se-
quences of variable chains of antibodies are amplified from template and variety of 
combinations are created, and then inserted into the CDR loops. (Weber et al., 2014) 
The templates are selected from the framework which is suitable to each case. Synthetic 
library is getting a lot of attention nowadays because the selection of the framework can 
be done according to the targets and the suitable combinations of variable chain genes 
Figure 16. The order of the genes of light and heavy chains in a phagemid vector for 
(a) scFv and (b) Fab form. Abbreviations; CH heavy chain (constant), CL light chain 
(constant), VH heavy chain (variable), VL light chain (variable). Modified from 
(Hoogenboom et al., 1991) 
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could be used for the production of functional scFvs. Hence, it is more effective and 
stable to express the antibodies. (Huovinen et al., 2013; Knappik et al., 2000) 
The selection of the phage displaying the most desirable antibody fragment from the 
phage library is conducted very often with biopanning. The principle of biopanning is 
described in Figure 17. The antigens are commonly immobilized to the surface of a 
plate such as microtiter plate. This array is then exposed to the phage display, and only 
specific phages bind to the antigens. Then, the phages which did not bind to the antigens 
are washed away, and the rest is eluted by dropping pH. After that, E. coli is infected 
with these phages, and they are amplified again. The amplified phages are again panned 
repeating the same process. By conducting this process for several times, the phage dis-
playing an antibody having the most affinity and the specificity can be isolated. In the 
end, the antibody is sequenced and identified. (Ellis et al., 2012) In biopanning, the 
blocking agent such as BSA is used similarly as in immunoassay to block the unspecific 
bindings of the phages.  
 
The problem in biopanning is that the repetition of the amplification causing the loss of 
diversity (Derda et al., 2011). Therefore, it is important to reduce the number of the 
panning rounds. One of the methods to improve the functionality of one panning round 
Figure 17. Principle of biopanning. Modified from (Ellis et al., 2012) The phage display 
is exposed to a surface with their antigens, and the phages displaying the antibodies with 
high affinity to the antigens bind to them. The ones which did not attach to the antigens 
are washed away, and the rest are eluted. The eluted phages are used to infect E. coli, 
and they are amplified again. This process is repeated for several times, and then the 
phage of interest can be isolated. Finally, the antibody which has the highest affinity can 
be identified.  
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could be to use biotin-streptavidin interaction. This interaction can be used in biopan-
ning too as in immunoassay. In this method, the plate is coated with streptavidin, and 
the phage displaying antibody is bound to biotin. For example, catalyzed reporter depo-
sition (CARD) could be utilized into biopanning as well as introduced by Maaβ (2014). 
It is a method to bind the biotin to protein in which horseradish peroxidase (HRP) works 
as a mediator of the binding of biotin to the protein with covalent bond in CARD. In 
this method, the HRP is attached to the antibody, and the antigen is bound to glucose 
oxidase (GOX). When glucose is added, GOX produces H2O2 which is necessary for the 
HRP to mediate the binding of the biotin to the surface of phage. Therefore, only the 
phages attached to the target antigen are bound to the streptavidin, enabling the selec-
tion of the antibody more efficient. (Maaß et al., 2014; Bobrow et al., 1989)  
3.3.5 Radioimmunoassay 
Immunoassay can be also categorized in a different way than competitive or non-
competitive. As mentioned above, there are many different “labels” for immunoassay, 
for example, radioisotope or enzyme. Furthermore, there are various types of signals to 
be obtained depending on the type of enzyme, such as chemiluminescense, fluores-
cence, electrochemiluminescense or absorbance. The antigens or the tracer antibodies 
can also be labeled directly with the substances which generate those signals. (Yalow 
and Berson, 1959; Schroeder et al., 1976; Blackburn et al., 1991; Dandliker, 2014) Ra-
dioimmunoassay is one of the types of different immunoassays.  
Radioimmunoassay was invented already in 1959 and opened the way of immunoassay. 
The antigen or the tracer antibody is labeled with radioisotopes in this type of immuno-
assay. It has been leading the bioanalysis of many different substances, for example, 
histamine in biological fluids, hepatitis B virus-associated delta antigen, and uroterosin 
for a long time because of its high sensitivity (Laroche et al., 1995; Rizzetto, Shin and 
Gerin, 1980; Aiyar et al., 2004; Launay et al., 2010). However, the risk of using radio-
active compounds has been considered as problematic, and as a consequence, the treat-
ment of the radioactive waste becomes more complicated. It has to be treated according 
to the rules decided by the municipality. (Sancho, Amal and Garcia-Fayos, 2013).  
In Table 1, the radioisotopes used frequently in radioimmunoassay and the important 
properties of them are listed. The radioisotope used the most these days is 
125
I because 
of its relatively long half-life and specific activity. 
125
I and 
131
I are both iodine, however, 
125
I is much more stable because its major radioactive emission does not have β. The 
radiation from 
125
I does not diffuse through glass or fabrics as easily as 
131
I, therefore it 
is easier to treat than 
131
I. 
3
H is also used especially for smaller molecules than the mol-
ecules which 
125
I are used for since 
125
I is moderately large. However, expensive liquid 
scintillation counting is required for 
3
H since its radioactivity is very low. For these rea-
sons, 
125
I is still preferred for radioimmunoassay.  (Lacy and O'Kennedy, 2005) 
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Table 1. Radioisotopes and their properties. Modified from (Edwards, 1991; Lacy and 
O'Kennedy, 2005). 
 
3.3.6 Enzyme immunoassay 
Enzyme immunoassay is a safer immunoassay technique than radioimmunoassay. The 
typical types of enzymes used for enzyme immunoassay are listed in Table 2. Alkaline 
phosphatase (phoA), horseradish peroxidase (HRP) and β-d-galactosidase are the most 
common enzymes as labels. These enzymes react with their specific substrates, such as 
p-nitrophenyl phosphate (pNPP), 3,3′,5,5′-tetratmethylbenzidine(TMB), and o-
Nitrophenyl-,3-D-galactopyranoside (ONPG), and the products of the reaction show 
different color from the reacted substrate. When alkaline phosphatase reacts with pNPP 
and when β-d-galactosidase reacts with ONPG, the color of the liquid changes to yellow. 
In the case of HRP and TMB, the color changes to blue. The change of the colors makes 
it possible to investigate the strength of the signals by measuring the absorbance at spe-
cific wavelength. (Giunta and Groppa, 1983; Tang, Tang and Yang, 2015; Busa et al., 
2016) The same enzymes can react with chemiluminescence substrate and produce 
chemiluminescence too (Dai et al., 2015; Shu et al., 2016).  
 
3.4 Functional Protein Microarray 
Functional protein microarray works in an almost same manner as analytical protein 
microarray, but does not use antibody-antigen interaction. In functional protein microar-
ray technique, the interaction between protein and, for example, protein, peptide, DNA, 
small molecules, and glycan are tested. (Sutandy et al., 2013) 
Radioisotope Half-life (t 1/2 )
Specific activity 
(Ci mmol
−1
)
Major 
radioactive 
emission
14
C 5730 years 0.07 β
3
H 12.3 years 33 β
125
I 60 days 2560 ϒ
131
I 8.04 days 19250 β/ϒ
Target Enzyme Source
Mycotoxins Alkaline phosphatase Burmistrova (2013)
Horseradish peroxidase
Adenosin3',5'-monophosphate β-d-galactosidase Yamamoto (1981)
3-amino-5-methylmorpholino-2-
oxazolidinone Alkaline phosphatase
Wang (2016)
Horseradish peroxidase
Ractopamine Alkaline phosphatase Dong (2012)
Table 2. Examples of enzymes used for enzyme immunoassay and the target proteins. 
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The aim of functional protein microarray is not to detect specific target, but to under-
stand the properties of proteins in cells. In these cases, proteins are immobilized to the 
microarray, and the substances are added to bind to the proteins.  
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4. MATERIALS AND METHODS 
4.1 Bacterial Strains 
The bacterial strains and the plasmids used in this study are listed in Table 3. The types 
of the cells or plasmids and the important characteristics of them are listed. A. baylyi 
ADP1 wild type has the pathway to produce the wax ester, and long-chain aldehyde is 
one of the intermediates involved in the pathway. The long-chain aldehyde is used as a 
substrate by LuxAB and ADO.  
 
4.2 Preparation of Media for Cultivation 
The media used in this study are Luria-Bertani (LB) medium, Low Salt LB medium, 
Luria agar (LA) plates, and Super Broth (SB) medium (Table 4). LB medium consisted 
of 10 g/l tryptone, 5 g/l yeast extract, and 5 g/l sodium chloride. Low Salt LB medium 
Cell or plasmid types Important characteristics of  the cells or the plasmids Sources
Host cell
Escherichia coli 
(E. coli) Origami B
Kanamycin and tetracyclin resistance.
Enables formation of disulfide bonds in cytoplasm. 
Improved production of scFv folded correctly.
High productivity of scFv-BCCP fusion protein 
using pAK400cB vector. 
Novagen®
Jurado (2002)
Santala (2003)
E. coli  KRX Rhamnose promoter. Promega
E. coli  XL1 Tetracyclin resistance. Stratagen
Acinetobacter baylyi 
(A. baylyi) ADP1 
Wax ester production pathway. DSMZ, Germany
A. baylyi ADP1 
ΔpoxB::iluxAB_Cm ʳ 
PoxB is knocked out from A. baylyi ADP1 wild 
type and Gene cassette iluxAB_Cmʳ  is integrated.
Containing LuxAB, T5 promoter and 
chloramphenicol resistance genes.
Santala (2011)
Plasmid
SpT5.10/pAK400cB SpT5.10-BCCP fusion gene, chrolamphenicol 
resistance, lac promoter.
Santala (2003)
pAK400cB-ADO or 
LuxAB specific scFvs
ADO or LuxAB specific scFv-BCCP fusion gene, 
chrolamphenicol resistance, lac promoter.
This study
pETM-14-ADO ADO gene, kanamycin resistance gene. Manuscript in preparation
pETM-28-LuxAB LuxAB gene, kanamycin resistance gene. Manuscript in preparation
pLK06H PhoA gene, ampicillin resistance gene. Huovinen (2013)
pLK06H-ADO or 
LuxAB specific scFvs
ADO or LuxAB specific scFv-phoA fusion gene, 
chrolamphenicol resistance, lac promoter-operator, 
pectate lyase B coding gene, ampicillin resistance 
gene.
This study
pBAV1C-ara-ado ADO gene, arabinose promoter, chloramphenicol 
resistance gene.
Manuscript in preparation
Table 3. Bacterial strains and the plasmids used in this study. 
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consisted of the same concentration of tryptone and yeast extract as LB medium, but it 
contained 1 g/l sodium chloride instead of 5 g/l of it. LA plates contained 15 g/l agar in 
addition to the same composition of LB medium. SB medium consisted of 30 g/l tryp-
tone, 20 g/l yeast extract, and 10 g/l MOPS buffer.  
Table 4. pH, components, and concentrations of the components of the media used in 
this study for the cultivations. 
 
The pH was adjusted to 7.0 for all of the cultures, and they were autoclaved after pH 
adjustment. LA plates were distributed to petri dishes after autoclaving.  
4.3 Constructing the pAK400cB-ADO or LuxAB specific scFv 
plasmids  
pAK400cB-ADO or LuxAB specific scFv, the plasmids containing scFv-BCCP fusion 
genes, were constructed for the sandwich immunoassay. pAK400cB vector was selected 
because it has been used for scFv-BCCP fusion protein previously in Santala (2004). 
Restriction, electrophoresis, gel extraction, polymerase chain reaction (PCR), and liga-
tion were all done in the same way every time unless otherwise mentioned.  
First, SpT5.10/pAK400cB plasmid was restricted with restriction enzymes NdeI and 
EcoRI to remove the original scFv gene SpT5.10. The restriction was conducted with 
1µg of plasmids per 20µl of restriction sample, Buffer O (Thermo Scientific, USA), 
NdeI (Thermo Scientific, USA), EcoRI (Thermo Scientific, USA), and double distilled 
water to adjust the final volume according to the amount of each reagent. The restriction 
samples were incubated at 37 degrees for more than 2 hours.  
Medium pH Components 
Concentrations 
of the 
components (g/l)
Luria-Bertani (LB) medium 7.0 Tryptone 10
Yeast extract 5
Sodium chloride 5
Low Salt LB medium 7.0 Tryptone 10
Yeast extract 5
Sodium chloride 1
Super Broth (SB) medium 7.0 Tryptone 30
Yeast extract 20
MOPS buffer 10
Luria agar (LA) plates 7.0 Tryptone 10
Yeast extract 5
Sodium chloride 5
Agar 15
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After the restriction, the product was run in electrophoresis and the restricted vector was 
extracted from the gel. For the electrophoresis, the restriction product was mixed with 
6x MassRuler DNA Loading Dye (Fermentas, USA) and run in 1% agarose gel. Gene-
Ruler DNA Ladder Mix ready-to-use (Fermentas, USA) was used as a ladder. The ex-
traction of the vector was done using GeneJET Gel Extraction Kit (Thermo Scientific, 
USA).  
After that, luxAB Vibrio fischeri gene was amplified from plasmid BBa_K325909 (ob-
tained from Registry of Standard Biological Parts) and restricted with restriction en-
zymes NdeI and EcoRI. The amplification was done using primers sa10 and sa9 (Ap-
pendix A, Table 6) by PCR with T3000 Thermocycler (Biometra, Germany). PCR was 
conducted with 170 ng of template plasmid, 2.5x10
-5
 µmol of Primers, Phusion Hot 
Start II (Thermo Scientific, USA) as an enzyme, 5xPhusion® HF Reaction Buffer 
(Thermo Scientific, USA), 1.25x10
-4
 mmol of dNTP, and double distilled water to ad-
just the final volume to 50 µl according to the amount of other reagents. Touchdown 
PCR was used for every PCR process.  
After PCR, PCR product was purified by GeneJet PCR purification kit (Fermentas, 
USA). Then, restriction of the PCR products was conducted with 800 ng of PCR prod-
uct instead of the plasmids. The restricted gene was run in electrophoresis and extracted 
from the gel. After that, this restricted LuxAB V. fischeri was ligated into restricted 
pAK400cB to construct cloning vector for the scFv-BCCP plasmids. Ligation was con-
ducted with 50 ng of restricted vector, 40 ng of restricted PCR product, T4 DNA Liga-
tion Buffer (Thermo Scientific, USA), T4 DNA Ligase (Thermo Fisher Scientific, 
USA), and double distilled water to adjust the total volume to 30 µl. The solution was 
kept for more than 1 hour for the ligation reaction at room temperature. Finally, 
pAK400cB vector containing LuxAB V. fischeri (cloning vector) was constructed.  
Next, pLK06H-ADO or LuxAB specific scFv plasmids were amplified by PCR (Figure 
18(a)). These plasmids were given as kind gifts from Urpo Lamminmäki, University of 
Turku. PCR and purification of the products were done in the same way as above except 
that the primers rm 13_2 and rm 13_1 (Appendix A, Table 6Table 6) were used. The 
scFv genes specific to ADO were EB34_B8, D3, D11, F3, G2, G8 and G10, and the 
ones specific to LuxAB were EB33_D6, D7, F10 and G4. Once they have been purified, 
these PCR products and the cloning vector were restricted and extracted from the gel 
after electrophoresis.  
Finally, the scFv genes were ligated with the cloning vector. As a result, pAK400cB-
ADO or LuxAB specific scFv plasmids were constructed (Figure 18(b)). The construct-
ed plasmids were restricted with enzymes EcoRI and NdeI and run in electrophoresis for 
confirmation. Electrophoresis was conducted in the same way as above, but GeneRuler 
DNA Ladder Mix ready-to-use (Fermentas, USA) was used for the construction of 
plasmids containing LuxAB specific scFvs, and Generuler 100bp plus ready-to-use 
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(Thermo Scientific, USA) was used for the construction of plasmids containing ADO 
specific scFvs. 
 
 
4.4 Transformation 
Transformation of pLK06H-ADO or LuxAB specific scFv plasmids and pAK400cB-
ADO or LuxAB specific scFv plasmids into cells was conducted for protein expression. 
pLK06H-ADO or LuxAB specific scFv plasmids were transformed into E. coli XL1 and 
pAK400cB-ADO or LuxAB specific scFv plasmids were transformed into E. coli Ori-
gami B, respectively. The transformations for the both plasmids were done using elec-
troporation in the same way as described below. 
Firstly, 2 µl of plasmid was added to 40 µl of corresponding competent cell and this 
mixture was moved to a BIO-RAD Gene Pulser cuvette. Then, this cuvette was placed 
into BIO-RAD MicroPulser
TM 
(BIO-RAD, USA), and switched on with Ec1 pro-
gramme. Right after that, 1 ml of LB medium was added to the cuvette and pipetted 
gently. Then, the mixture including LB medium was moved to a 1.5 ml Eppendorf tube 
and incubated at 37 degrees for 1 hour.  
After the incubation, it was spread on LA plate and incubated again at 37 degrees over-
night. The colonies obtained from LA plates were picked and cultivated in appropriate 
media according to the cell types and the plasmid types for lysate preparation for sand-
wich immunoassay. 
 
(a) (b) 
Figure 18. Plasmids used in this study; (a) pLK06H-ADO or LuxAB specific scFv and 
(b) pAK400cB-ADO or LuxAB specific scFv. Abbreviations: BCCP biotin carboxyl car-
rier protein, CMR chloramphenicol resistance gene, LacPO Lac promoter-operator, 
pelB pectate lyase B coding gene, and scFv single-chain variable fragment. 
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4.5 Lysate preparation 
Lysates were prepared for the immunoassays using the cells harbouring plasmids and 
the ones without plasmids. All the cells were cultivated in suitable media. The cell types 
for each plasmid, the type of the media, the antibiotics added to the media and their 
concentrations and inducers used are listed in Table 5. Different media were used for 
the same type of host cells for different purposes. 
 
4.5.1 Lysates for the immunoassays for finding the best combi-
nations of scFvs 
First, all the cells other than A. baylyi ADP1 were cultivated at 30 degrees and 300 rpm 
overnight. In addition to the antibiotics, every culture contained 250 µmol/l of isopropyl 
β-D-1-thiogalactopyranoside (IPTG) for induction and 0.4% of glucose as nutrition. 
Rhamnose was also added to the culture of KRX cells harbouring pETM-28-LuxAB or 
pETM-14-ADO for the induction purpose, and the concentration was 0.1 %. KRX cells 
were all cultivated in SB medium for this experiment. 4 µM of biotin was added to the 
culture of Origami B for the biotinylation.  
After cultivation, the cells were harvested by centrifugation at 6000g for 5 minutes. 
Then, the harvested cells were re-suspended to assay buffer in Eppendorf tubes, and 
about 1mg of lysozyme from chicken egg white was added to each tube. Assay buffer 
contained 50mM Tris-HCl (pH8), 150mM sodium chloride, 0.1% bovine serum albu-
min (BSA), and 0.01% Tween 20. Next, the tubes having re-suspended cells and lyso-
zyme were incubated at 37 degrees for cell lysis for 1 hour.  
Host cell
Type of 
medium
Plasmid contained
Antibiotics added to 
medium (µg/µl)
Inducer 
Escherichia coli 
(E. coli) Origami B
SB
pAK400cB-ADO or LuxAB 
specific scFvs
Chloramphenicol 25 µg/µl, 
tetracyclin 10 µg/µl, 
kanamycin 30 µg/µl
Isopropyl β-D-1-
thiogalactopyranoside 
(IPTG)  250 μM
E. coli  KRX SB 
pETM-14-ADO or 
pETM-28-LuxAB
Kanamycin 50 µg/µl
IPTG 250 μM, rhamnose 
0.1 %
E. coli  KRX Low salt LB pETM-14-ADO Kanamycin 50 µg/µl
IPTG 250 μM, rhamnose 
0.1 %
E. coli  KRX LB
pETM-14-ADO or 
pETM-28-LuxAB
Kanamycin 50 µg/µl
IPTG 250 μM, rhamnose 
0.1 %
E. coli  XL1 SB
pLK06H-ADO or LuxAB 
specific scFvs
Tetracyclin 10 µg/µl, 
ampicillin 100 µg/µl
IPTG 250 μM
E. coli XL1 SB or LB No plasmids Tetracyclin 10 µg/µl
IPTG 250 μM, rhamnose 
0.1 %
Acinetobacter baylyi 
(A. baylyi) ADP1 
Low salt LB pBAV1C-ara-ado Chloramphenicol 25 µg/µl Arabinose 1%
A. baylyi ADP1 
ΔpoxB::iluxAB_Cm ʳ 
Low salt LB No plasmids Chloramphenicol 25 µg/µl No inducers
A. baylyi ADP1 Low salt LB No plasmids No antibiotics Arabinose 1%
Table 5. Cell types used for each plasmid and antibiotics used during cultivation. Ab-
breviations: ADO aldehyde-deformylating oxygenase, LB Luria-Bertani, LuxAB bacte-
rial luciferase, SB Super Broth, scFv single-chain variable fragment.  
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After 1 hour, they were taken out from the incubator and placed into -80 degrees freezer 
and 37 degrees incubator alternately for 3 times also to lyse the cells. The lysed cells 
were centrifuged and the supernatant was aliquoted. This supernatant was the lysate to 
be used for the immunoassay, and they were kept in 4 degrees fridge before use.  
4.5.2 Lysates for the immunoassays for standard curves and 
for protein expression check with A. baylyi ADP1 
The lysate preparation for these purposes was conducted using flasks for the main culti-
vation. First, pre-cultivation of all the cells were conducted with 5 ml cultivation tubes 
with appropriate media in the same way as section 5.4.1 without the inducers. The tubes 
were incubated at 30 degrees and 300 rpm overnight.  
After the pre-cultivation, the OD600 of all the cells was measured, and they were cul-
tured into the main culture in suitable sized flasks. The starting OD600 of the main culti-
vation was adjusted to 0.01 other than Origami B and XL1 harbouring pLK06H-ADO 
or LuxAB specific scFv which started with OD600 0.02. The main culture included the 
same components as the pre-culture. The cells were cultivated at 37 degrees at 300 rpm.  
After the OD600 of the main cultures has reached from 0.5 to 1, suitable inducers were 
added to the culture at the appropriate concentration. For A. baylyi 
ADP1ΔpoxB::iluxAB_Cm r, no inducers were added because it contains T5 promoter. 
The culture containing Origami B strain was cultivated for 48 hours at 26 degrees at 300 
rpm, but all the others were cultivated only 24 hours. 
4.6 Immunoassays 
Many different types of immunoassays have been conducted during this study. Firstly, 
ADO sandwich immunoassay and LuxAB capture assay were conducted to select the 
best-working combinations of the scFvs. After that, another ADO sandwich immunoas-
say and LuxAB capture assay were conducted to draw standard curves for the best com-
bination of ADO-specific scFvs and the best-working capture LuxAB-specific scFvs. 
Finally, the established immunoassay systems were applied with ADO and LuxAB pro-
duced by A. baylyi ADP1.  
All types of immunoassays were performed using KaiSA96-Lockwell Streptavidin mi-
crotiter plate (Kaivogen, Finland). Incubation and washing of the plate were conducted 
in the same way in all the immunoassays otherwise mentioned.  
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4.6.1 ADO sandwich immunoassay for selecting the best-
working combination of scFvs 
This sandwich immunoassay was conducted to select the best-working combination of 
scFvs (Figure 19). Firstly, 100 µl of each pAK400cB-ADO specific scFvs/E. coli Ori-
gami B lysate was added to each well of the plate. The plate was incubated at room 
temperature at slow shaking for 1 hour. Then, the plate was washed 4 times per each 
well with wash buffer with Elisa program with Hydroflex (Tecan, Switzerland). Wash 
buffer contained 5mM Tris-HCl (pH8), 150mM sodium chloride, and 0.01% Tween 20. 
The incubation and the washing of the wells were done in the same way below for the 
other types of immunoassays. After that, 100µl of pETM-14-ADO/KRX lysate was 
added as an antigen to each well. Then, the plate was incubated and washed again. Next, 
100 µl of each pLK06H-ADO specific scFv/E. coli XL1 lysate was added to each well. 
After that, the plate was incubated and washed. Finally, 100 µl of alkaline phosphatase 
yellow (pNPP) liquid substrate system for ELISA (Sigma-Aldrich, USA) was added to 
each well and the plate was incubated at 37 degrees at 150 rpm for 1 hour. All the com-
binations of scFvs were tested as duplicate. After the final plate incubation, the absorb-
ance at 405nm was measured for each well with Multiskan Ascent 96 plate reader 
(Thermo Scientific, USA).  
All the combinations of scFvs were tested. In addition to that, negative controls were 
also tested for each antibody combination in sandwich immunoassay. E. coli XL1 cells 
without protein expression (XL1 empty) were used instead of antigen in the negative 
controls. The results were calculated by dividing the absorbance by the absorbance of 
the corresponding negative controls lacking antigen. 
 
Figure 19. Schematic picture of ADO sandwich immunoassay. The surface of the plate is 
coated with streptavidin, and the biotin molecule binds to it. Capture scFv is fused with 
biotin, and this scFv captures ADO. ADO is then again captured by tracer scFv, and 
phoA attached to the tracer scFv react with its substrate pNPP. The absorbance is meas-
ured in the end as a signal. Abbreviations: ADO aldehyde-deformylating oxygenase, 
phoA, alkaline phosphatase, pNPP alkaline phosphatase yellow, scFv single-chain vari-
able fragment. 
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4.6.2 LuxAB capture assay for selecting the best-working scFvs 
This assay was conducted to select the best-working capture scFvs for LuxAB. 
Firstly, the plate was washed in the same way as described in section 5.5.1. After that, 
200 µl of pAK400cB-LuxAB specific scFvs/E. coli Origami B lysates were added to the 
wells, and the plate was incubated and washed. After that, 200 µl of pETM-28-
LuxAB/KRX lysate was added to the wells and the plate was incubated and washed. 
Then, 150 µl of XL1 empty expression lysate, 45 µl of assay buffer, and 5 µl of decanal 
stock were added to the wells. Decanal stock consisted of 1 ml of 99.6 % ethanol and 20 
µl of decanal. After the addition of decanal, luminescence was measured for each well. 
The ones showing the highest luminescence were selected as the best. All the types 
were tested as duplicate. 
All the pAK400cB-LuxAB specific scFvs/E. coli Origami B lysates were tested, and the 
negative controls were also tested. For the negative controls, XL1 empty lysate was 
used instead of pAK400cB-LuxAB specific scFvs/E. coli Origami B lysate. The results 
were calculated by dividing the absorbance by the absorbance of the negative control.  
 
4.6.3 Sandwich immunoassay and LuxAB capture assay for 
drawing a standard curve 
After finding the best combination (D11-BCCP and D3-phoA) of ADO-specific scFvs, 
another sandwich immunoassay was conducted to draw a standard curve with the se-
lected combination. Only the combination of D11-BCCP and D3-phoA was tested. All 
the samples were tested as triplicate samples.  
Figure 20. Schematic picture of LuxAB capture assay. The surface of the plate is coated 
with streptavidin, and the biotin molecule binds to it. Capture scFv is fused with biotin, 
and this scFv captures LuxAB. After the LuxAB has been captured, decanal and XL1 
lysate is added to the well. Then, luminescence is measured as signal. Abbreviations: 
LuxAB bacterial lusiferase, scFv singl-chain variable fragments. 
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This sandwich immunoassay was mainly conducted in the same way as sandwich im-
munoassay for finding the best scFvs, but the plate was washed before the first addition 
of the lysate and the volume of pETM-28-ADO/KRX lysate was different. To draw the 
standard curve, 0 µl, 0.5 µl, 1 µl and 5 µl of the lysate was used. Negative controls were 
tested using XL1 empty lysate instead of D11-BCCP lysate with all different volumes 
of pETM-28-ADO/KRX lysate.  
Similarly, after finding the best working capture scFvs (D7 and G4), another LuxAB 
capture assay was conducted to draw standard curves with the selected scFvs.  Only D7 
and G4 were tested as capture scFvs. All the samples were tested as triplicate samples. 
The assay was conducted in the same way as 5.5.2 except that many different volumes 
of pETM-14-LuxAB lysate were used for drawing standard curves. The used volumes 
of the lysate were 0 µl, 10 µl, 20 µl, 30 µl and 40 µl. Negative controls were tested us-
ing XL1 empty lysate instead of D7 or G4 lysates with all different volumes of pETM-
14-LuxAB lysate. 
4.6.4 Sandwich immunoassay and LuxAB capture assay with 
A.baylyi ADP1 
After drawing standard curve for sandwich immunoassay and capture assay with anti-
gens expressed by E. coli KRX, these assay systems were tested if they could also work 
with ADO and LuxAB expressed by A. baylyi ADP1. The sandwich immunoassay and 
LuxAB capture assay were conducted in the same way as 5.5.3 and 5.5.2 including the 
negative controls, respectively, except that pBAVIC-ara-ado/A. baylyi ADP1 lysate and 
A. baylyi ADP1ΔpoxB::iluxAB_Cm r were used. For LuxAB capture assay, ADP1 empty 
lysate was used for the negative control. The volumes of pBAVIC-ara-ado/A. baylyi 
ADP1 lysate were 0µl, 200µl, 400µl, 600µl and 800µl. The volumes of A. baylyi 
ADP1ΔpoxB::iluxAB_Cm r lysate were 0µl, 50µl, 100µl, 150µl, and 200µl. All the sam-
ples were tested as triplicate samples. 
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5. RESULTS  
5.1 Construction of pAK400cB-ADO or LuxAB specific scFvs   
The plasmids, pAK400cB-ADO or LuxAB specific scFvs, were constructed in order to 
obtain scFvs fused with BCCP for the ADO sandwich immunoassay and LuxAB cap-
ture assay with streptavidin coated microtiter plate.  
The results of the electrophoresis of restricted pAK400cB-ADO or LuxAB specific 
scFvs plasmids are shown in Figure 21. As it can be seen, the bands for the inserts (scFv 
genes) are at around 800bp for all of them other than the first G8, the first two F10 and 
the last two F10 (from left). Therefore, it can be said that the plasmids other than the 
ones mentioned are successfully constructed.  
 
 
(a) 
(b) 
(a) 
(b) 
Figure 21. Results of the electrophoresis of restricted pAK400cb-ADO or LuxAB spe-
cific scFv plasmid; (a) aldehyde-deformylating oxygenase (ADO) specific scFv contain-
ing plasmid and (b) Bacterial luciferase (LuxAB) specific scFv containing plasmid. 
Control was the background for ligation which had double distilled water instead of 
insert for the ligation. 
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5.2 Immunoassays 
5.2.1 Finding the best scFvs 
ADO sandwich immunoassay and LuxAB capture assay were conducted to select the 
best-working combinations of ADO-specific antibodies and the best capture LuxAB-
specific scFvs. The results for ADO sandwich immunoassay are shown in Figure 22(a). 
As it can be seen, the combination of D11 as a capture scFv and D3 as a tracer scFv 
works by far the best with this system, showing 2.56 times bigger absorbance than its 
negative control.   
For LuxAB capture assay, the results are shown in Figure 22(b). As a result, G4 and D7 
showed the best results by showing 1.61 times and 1.50 times bigger luminescence 
compared to the negative control, respectively.  Though G4 showed a big error bar, it 
could still be considered as a candidate because only duplicate samples were tested.  
 
 
Figure 22. Results of (a) ADO sandwich immunoassay and (b) LuxAB capture assay  for 
the best scFv selections. In (a), the names of the scFv combinations of are shown as cap-
ture scFv-tracer scFv (e.g. B8-D11 means that the capture scFv was B8 and the tracer 
scFv was D11.)   
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5.2.2 Standard curve 
The standard curves drawn by ADO sandwich immunoassay and LuxAB capture assays 
with the best scFvs are shown in Figure 23 (a) and (b), respectively. As results of the 
assays, clear standard curves were drawn for both ADO and LuxAB assays. This indi-
cates that the combination of the ADO-specific scFvs and the LuxAB scFvs worked in 
these immunoassay systems.   
 
 
Figure 23. Standard curves of (a) ADO sandwich immunoassay and (b) LuxAB cap-
ture assay. For ADO immunoassay, the combination of scFvs were D11 and D3. For 
LuxAB capture assay, scFvs G4 and D7 were used. 
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5.2.3 Immunoassays with antigens expressed by A.baylyi ADP1 
After the assay systems have been tested and confirmed by drawing the standard curve, 
the systems were applied into analysis of the protein expression by A. baylyi ADP1. As 
it can be seen clearly in Figure 24 (a) and (b), no co-relationships between the volume 
of ADO or LuxAB lysate and the signals were obtained.  In addition, the signals were as 
small as the negative controls in both cases.  
 
Figure 24. The results of (a) ADO sandwich immunoassay and (b) LuxAB capture assay 
with the antigens produced by A. baylyi ADP1. In (a), A. baylyi ADP1 was induced by 
Arabinose in “ADP1 induced” and it was not induced in “ADP1 not induced”. In (b), 
D7 and G4 are tested with D7 and G4, respectively. XL1 is the one which did not con-
tain scFvs, but XL1 empty lysate was used instead of them (negative control).  
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6. DISCUSSIONS AND CONCLUSIONS 
Cell factory construction has been drawing a lot of attentions nowadays because of its 
potentiality to replace for the traditional production of valuable products from fossil 
fuels. To construct useful cell factories, there must be easy and accurate tools to analyse 
them. In this study, analytical tools for the ADO producing bacteria and LuxAB produc-
ing bacteria were constructed. ADO is an interesting target enzyme because it is in-
volved in fatty alkanes or alkenes production in bacteria. Fatty alkanes and alkenes are 
the main components in the fuels used widely in the world (Mabuza, 2011; Howard et 
al., 2013). LuxAB is an enzyme which is able to produce bioluminescence, enabling it 
to be used as a bioreporter. As a bioreporter, it can be utilized as a real-time monitoring 
tool for a production of certain compounds in bacteria. Measurement of the biolumines-
cence produced by LuxAB during cultivation is the signal of the production of the target 
protein. However, the production of LuxAB itself needs to be studied more by other 
methods.  
Here, a simple and easy method, immunoassay, was investigated as an analytical tool 
for ADO and LuxAB for the reasons above. Immunoassay is much simpler and cheaper 
compared to MS which has been used for proteomic analysis. It is because MS requires 
expensive equipment, such as ionization source, mass analyser and detector, and also 
that the capability of using those equipment is required for the researchers. On the other 
hand, immunoassay requires only the lysates of the cells, microtiter plates, incubators, 
and signal readers, for example, absorbance or luminescence measurer. Moreover, the 
use of the equipment does not need any special skills. Though immunoassay is a simple 
method, it possesses high accuracy because antibody-antigen interaction is utilized. En-
zyme immunoassay is particularly important type of immunoassays in order to achieve 
simpler immunoassay system since no special skills are required as in radioimmunoas-
say. The use of streptavidin-biotin interaction also helps to improve the accuracy of the 
immunoassay maintaining the easiness of the system.  
In this study, enzyme sandwich immunoassay for ADO (ADO sandwich immunoassay) 
and a new type of immunoassay for LuxAB (LuxAB capture assay) with scFvs were 
constructed. In LuxAB capture assay, LuxAB is captured by the capture scFvs and pro-
duces luminescence using the added decanal as a substrate. E. coli Origami B and E. 
coli XL1 were engineered to produce scFvs for the immunoassays, and the immunoas-
say systems with the best scFvs were then tested with ADO or LuxAB producing E. coli 
KRX first, and they were applied with A. baylyi ADP1 producing those proteins.  
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The plasmids pAK400cB-ADO or LuxAB specific scFvs were constructed with PCR to 
modify E. coli Origami B to be able to produce ADO or LuxAB specific scFvs, respec-
tively. As the capture scFvs need to be fused with biotin, vector pAK400cB was select-
ed. For the tracer scFvs, vector pLK06H was selected since the scFvs need to be fused 
with phoA. These plasmids were all constructed successfully and were transformed into 
corresponding E. coli strains.  
After the construction of the engineered E. coli strains, the best scFv pairs and scFvs for 
ADO sandwich immunoassay and LuxAB capture assay were selected by conducting 
the actual immunoassays. The best scFv pairs and scFvs were defined as the ones giving 
the highest signal compared to the negative controls through this study. At this stage, E. 
coli KRX producing ADO or LuxAB were used to confirm the assay systems. Absorb-
ance for ADO sandwich immunoassay and luminescence for LuxAB capture assay were 
measured, respectively. It was found out in this study that D11 as a capture scFv and D3 
as a tracer scFv (D11-D3) is by far the best combination for ADO sandwich immunoas-
say. Correspondingly, D7 and G4 are the best working scFvs for LuxAB capture assay. 
For LuxAB, LuxAB sandwich immunoassay was also tested, but no combinations of 
scFvs worked (results not shown). After the selection, the assays with the best scFvs 
were conducted to draw standard curves. Standard curves were drawn for all the types 
of the assays, therefore it could be concluded that all the scFvs were able to detect the 
targets correctly, and the system worked properly with these scFvs. From this result, it 
can be also said that an immunoassay in which antigen itself generates the signal is eli-
gible too as in LuxAB capture assay.   
The immunoassay systems confirmed were finally tested with the A. baylyi ADP1 pro-
ducing ADO or LuxAB. The strains were engineered to produce wax ester, and they 
generate long-chain aldehyde as an intermediate during the wax ester production 
(Santala et al., 2011). As a result, no relationships between the volume of the lysates 
and the signals were observed. Since the system was confirmed to be working in the 
previous experiments, it could be considered that the reasons why it did not work this 
time are in the strains. The possible reasons could be that the strains do not produce 
ADO or LuxAB or produce so small amount of them that the system could not detect 
them.  
The strain A. baylyi ADP1 harbouring pBAVIC-ara-ado has been constructed in labora-
tory in Tampere University of Technology, but the manuscript is still in progress as de-
scribed in Table 3. Therefore, the production of ADO is not analysed with any other 
method yet. Moreover, the sensitivity of the sandwich immunoassay constructed in this 
study has not been accurately tested. Therefore, it is possible that the strain does not 
produce any ADO, but there also remains the possibility that the strain produces too 
small amount of ADO for ADO sandwich immunoassay. In this study, lysate of E. coli 
containing ADO was used for the immunoassay, but the exact amount of ADO was not 
measured. For this reason, the sandwich immunoassay system has to be tested with 
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known amount of ADO to investigate the minimum and maximum amount of ADO that 
can be detected.  
The strain A. baylyi ADP1 ΔpoxB::iluxAB_Cmʳ was constructed and it was proved that 
luminescence was produced during the wax ester production by Santala (2011). Howev-
er, the amount of LuxAB produced was not measured. Additionally, the amount of 
LuxAB lysate was increased only to 200 µl in this study. Considering these facts, the 
strain produces LuxAB, but the amount of LuxAB contained in the lysate was not 
enough to be detected in this system. So, LuxAB capture assay system must be tested 
with bigger amount of lysate. If the LuxAB cannot still be detected with bigger amount, 
such as 800µl, the sensitivity of this LuxAB capture immunoassay should also be tested 
similarly to ADO sandwich immunoassay.  
The immunoassays constructed in this study give a possibility to analyse the proteomics 
of the cell factories engineered to produce valuable products. In this case, wax ester 
production and alkane or alkene production were the targets. In this study, the systems 
were successfully constructed, but they were not yet applicable with A. baylyi ADP1 
strains producing the target products. Thus, it will be necessary to examine the sensitivi-
ties of the systems, and also to increase the amount of the lysates to be analysed. How-
ever, this study provides a good foundation for the novel immunoassay systems. These 
systems will enable researchers to analyse proteomics more cheaply and effortlessly 
than what is currently possible, thus helping to develop more of novel bacterial cell fac-
tories producing valuable products.   
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APPENDIX A: THE PRIMERS USED IN THIS STUDY 
The primers used in this study are shown in Table 6 below.  
 
Name
Length
 (base pairs) Description Oligo sequence
sa10 43
PCR antisense primer, V. fischeri luxAB, 
EcoRI, TAA, BamHI
ATTGGGATCCTTAGAATTCTGGTAAATTCATTTCGATTTTTTG 
sa9 51
PCR sense primer, V. fishceri luxAB, 
XbaI, RBS, NdeI
AATTTCTAGAGAAGGAGATATACATATGAAGTTTGGAAATATTTGTTTTTC 
rm13_2 23
PCR antisense primer, 
For cloning scFvs from pAK to p1.3Tc, EcoRI
TCCGGAATTCGGCCCCCGAGGCC
rm13_1 32
PCR sense primer, 
For cloning scFv from pAK to pAK400c, NdeI
CAATCATATGGAAATTGTGCTGACCCAATCTC
Table 6. The description of oligo sequences of the primers used in this study. 
